| 摘要 |
The present invention relates to suspension formulations, especially those for delivering a pharmaceutically active agent in aerosol form using a spray or aerosol device, such as a pressurised metered dose inhaler (pMDI). The formulations may be for pulmonary, nasal, buccal or topical administration, but are preferably for pulmonary inhalation. |
| 申请人 |
VECTURA LIMITED;INNOVATA BIOMED LIMITED;WHITFIELD, NICOLA, KIM;LEWIS, DAVID, ANDREW;KEEBLE, CHRISTINA, ALEXANDRA;CHURCH, TANYA |
发明人 |
LEWIS, DAVID, ANDREW;KEEBLE, CHRISTINA, ALEXANDRA;CHURCH, TANYA |
